Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical block for pain in laparoscopic myomectomy
NCT04068766Unknown
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in uterine fibroid, sponsored by Kangbuk Samsung Hospital. Primary endpoint: Postoperative pain at 6 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
uterine fibroid
Beyond the preview
Go deeper on NCT04068766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04068766.